• Home
  • Solusi Smart City Indonesia
  • Inquiry
  • About
Sabtu, Juni 6, 2026
Gamatechno, Gamatechno Smart City, Smart City Indonesia
No Result
View All Result
Blog Gamatechno
No Result
View All Result
Blog Gamatechno
No Result
View All Result
Home public

Coronavirus disease 2019

0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

ShareTweetPin

Related Posts

No Content Available

Must Read

Kelola Administrasi Perjalanan Dinas Perusahaan dengan Lebih Mudah
Technonews

Cara Mudah Kelola Manajemen Perjalanan Dinas Dengan Software GA

by Didik Fatmoko
November 3, 2023
0

Kamu staff General Affair, lakukan cara ini untuk kelola manajemen perjalanan dinas dengan software ga. Lebih praktis dan cepat dengan...

Read more
saas software as a service

Mengenal Software as a Service atau SaaS dan Benefit untuk Industri

Juli 11, 2023

Keuntungan Rekrutmen Karyawan Online Bagi Perusahaan

Maret 24, 2021

Perbedaan dan Keunggulan Software ERP Cloud dan On Premise

Juli 22, 2021
5 Tips Memilih Software ERP Terbaik Sesuai Dengan Kebutuhan Perusahaan

5 Tips Memilih Software ERP Terbaik Sesuai Dengan Kebutuhan Perusahaan

November 2, 2023
  • Home
  • About
  • Privacy Policy
  • Contact

© 2019 Gamatechno Blog. All Rights Reserved

No Result
View All Result

© 2019 Gamatechno Blog. All Rights Reserved

Login to your account below

Forgotten Password? Sign Up

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Go to mobile version